Results 211 to 220 of about 50,591 (247)

Plasma metabolomic profiling of diabetic macular edema. [PDF]

Sci Rep
Wang ZY, Yang FY, Cai SW, Tian W, Xie RR, Sun R, Zhu XR.   +6 more
europepmc   +1 more source

Refractory diabetic macular edema.

Journal of ophthalmic & vision research, 2010
openaire   +2 more sources

Treatment Trends of Diabetic Macular Edema in Korea (TRACK) Study: A Prospective Multicenter Study. [PDF]

Korean J Ophthalmol
Kim MS, Joo K, Shin YU, Cho HY, Lee JY, Sagong M, Kim JT, Kim YC, Kim HW, Kwak H, Ahn SJ, Lee MY, Bae JH, Chung I, Han YS, Yoo WS, Park S, Kim DG, Kang HM, Chin HS, Hwang DD, Ji YS, Park KH.   +22 more
europepmc   +1 more source

Ten-Year Follow-Up of Visual Outcomes After Vitrectomy for Clinically Non-Tractional Diabetic Macular Edema. [PDF]

Cureus
Kumagai K, Horie E, Fukami M, Furukawa M.   +3 more
europepmc   +1 more source

Real-world outcomes, including intraocular inflammation, after intravitreal brolucizumab for diabetic macular edema [PDF]

Takao Hirano, Yoshiaki Chiku, Ken Hoshiyama, Yoshiaki Takahashi, Shun Ito, Toshinori Murata   +5 more
openalex   +1 more source

Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema". [PDF]

Invest Ophthalmol Vis Sci
Yang Y, Zhang J.
europepmc   +1 more source

Efficacy and Safety of Faricimab in Diabetic Macular Edema: Real-World Outcomes in Treatment-Naïve and Previously Treated Eyes. [PDF]

J Clin Med
Esteban-Floría O, Mateo J, Lara J, Bartolomé I, Herrero I, Pérez MA, Cabello C, Honrubia A, Pinilla I, Ascaso J.   +9 more
europepmc   +1 more source

Association of serum proinflammatory factors with clinical response to ranibizumab for diabetic macular edema. [PDF]

Exp Ther Med
Gao X, Li H, Diao J, Liu D, Sun W, Zhou Z.   +5 more
europepmc   +1 more source

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes. [PDF]

Sci Rep
Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST.   +15 more
europepmc   +1 more source

Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings? [PDF]

Ophthalmol Ther
Peto T, Vujosevic S, Sheth V, Downey A, Gibson K, Pollreisz A.   +5 more
europepmc   +1 more source